Search:
 
This image is of a spacer graphic
NHF Face Book NHF Twitter
+ Login to my NHF
+ NHF Membership
+ Donate to NHF
+ Chapter Center
+ Hechos y Respuestas Rápidas
+ Ethics Advisory Committee
This image is of a spacer graphic
-Learn About Coagulation Disorders
-What are Bleeding Disorders?
 History of Bleeding Disorders
 Types of Bleeding Disorders
 Types of Bleeds
 Bleeding Disorders and Women
 Caring for the Newly Diagnosed Child
 Psychosocial Issues
-Complications, including Inhibitors
-Inhibitors
-For Consumers
 What is an Inhibitor?
 Who is at Risk for Developing an Inhibitor?
 How Do You Know If You Have an Inhibitor?
 Test Results
 Treatment
 Porcine Factor VIII
 Immune Tolerance
-Treatment Costs and Financial Considerations
 For Providers
 Discussion Group
 Future Therapies
 What are Clotting Disorders?
 Comprehensive Medical Care - Hemophilia Treatment Centers
 Medical and Scientific Advisory Council
 Financial and Insurance Issues
 HANDI, NHF's Information Resource Center
 Resources
 Web Links
 Glossary

 

 

 
Treatment Costs and Financial Considerations
 
 

The cost associated with treating the person who has inhibitors is often high, and the impact that this cost has on a person and/or family depends on the exact type of treatment as well as the insurance coverage.

If a person is being treated at a hospital, it is important to contact the department that oversees the financial issues associated with treatment. Often this is the finance department. The people in these departments can often find out if a treatment is covered by a person's insurance and to what degree. In many cases an insurance company will cover only a portion of a person's treatment.

In many hospitals there is a social work department that can assist people in identifying resources to help defray the costs of treatment.

There is often a significant difference between an inpatient hospital setting and an outpatient treatment facility in terms of insurance coverage.

In many outpatient settings there will be a person or department that can assist people in learning what is covered and what is the patient's responsibility.

Financial assistance may also available to people through their county's social services departments. In these cases financial need may have to be established.

Another option that may be worth exploring is "risk sharing." This is a program often setup by the manufacturers that produce the medications used to treat inhibitors that lower the costs associated with treatment for those with limited or no health insurance.

 


 

This section of our Web site is sponsored by: